
1. paediatr respir rev. 2004 dec;5(4):311-5.

respiratory manifestations hiv-infected children pre- post-haart in
abidjan, ivory coast.

kouakoussui a(1), fassinou p, anaky mf, elenga n, laguide r, wemin ml, toure r,
menan h, rouet f, msellati p.

author information: 
(1)projet enfant yopougon, pacci, abidjan, c√¥te d'ivoire.

among children infected human immunodeficiency virus (hiv), respiratory
diseases frequent cause morbidity mortality. review describes
respiratory manifestations paediatric hiv infection the
beginning haart abidjan, ivory coast. observational cohort, hiv
infected children quarterly clinical visits day-clinic available all
week ill children. cd4 viral load measured baseline every 6
months thereafter. children cd4 percentage 25% prescribed
daily cotrimoxazole prophylaxis. ninety-eight children (of total 282) were
recruited haart treated follow-up, 56 boys and
42 girls, mean age 6.2 years inclusion. mean percentage cd4
before haart 8.7%. twelve children history pulmonary tuberculosis
and five antituberculosis treatment inclusion. fifty-one per cent
presented abnormalities chest x-ray inclusion. initiation of
haart, respiratory manifestations represented 32.4% morbidity events the
incidence 100 child/months 9.29 urti, 15.2 bronchitis, 6.07 for
lrti, 0.71 tuberculosis 0.36 pneumocystis carinii. the
initiation haart, respiratory manifestations represented 40.9% all
morbidity events incidence 100 child/months 5.35 urti, 9.48
for bronchitis, 2.17 lrti 0.16 tuberculosis. haart treatment, 
the incidence respiratory infections decreased dramatically compared before
the antiretroviral treatment. however, respiratory events still represented 40%
of events occurring following start haart therapy.

doi: 10.1016/j.prrv.2004.07.008 
pmid: 15531256  [indexed medline]

